Everlab

Overview

Everlab is a pioneering health technology company based in Melbourne, Australia, with a focus on preventive healthcare. Founded in 2023 by Steven Lu, Marc Hermann, Anshul Jain, and Sam Kothari, Everlab leverages artificial intelligence to deliver comprehensive health assessments and personalized care plans. The company aims to detect diseases early, optimize well-being, and enhance life expectancy through a data-driven approach. Everlab has raised $10 million in seed funding as of 2025, signaling strong investor confidence in its innovative model.

Recent Developments

Recently, Everlab has made significant strides in expanding its market reach and technological capabilities:

  • July 2025: Everlab closed a $10 million seed funding round led by Left Lane Capital. The funds will bolster the expansion of Everlab’s clinic network and enhance its AI-powered infrastructure, crucial for scaling preventive health services globally.
  • July 2025: Co-founder and CEO Marc Hermann emphasized Everlab's impact, noting that 2.5% of members have life-changing discoveries, detecting critical health issues such as blocked arteries and early-stage cancers.
  • July 2025: The company is enhancing its service offerings by focusing on interoperability with existing health infrastructure, integrating data from national pathology and radiology systems to ensure continuity of care. This approach aims to reduce clinical review times significantly.
  • May 2025: Everlab announced plans to expand its presence across all major Australian cities, responding to growing consumer demand for its advanced health services.
  • 2024: Everlab continued to build its service offerings, integrating digital health records with real-time diagnostics, enabling better decision-making for health outcomes.

Company Information

AttributeInformation
Founding Date2023
HeadquartersMelbourne, Australia
FoundersSteven Lu, Marc Hermann, Anshul Jain, Sam Kothari
RevenueNot publicly disclosed
ProfitsNot publicly disclosed
Key InvestorsLeft Lane Capital
IndustryHealthcare, HealthTech
Number of EmployeesNot publicly disclosed

Early History

Founded in 2023, Everlab was created with the vision to transform preventive healthcare using advanced technology and innovative delivery models. The founding team, comprising of experienced professionals from technology and healthcare sectors, aimed to build a platform that could unify personal health data for more proactive healthcare management. Initially, their focus was on creating robust AI tools capable of not only assessing but also predicting health risks based on large datasets. The integration of comprehensive health assessments with personalized care plans quickly set Everlab apart in the health technology landscape.

Company Profile and Achievements

Everlab operates by offering various diagnostic and health assessment services through a subscription-based model. The company collects and analyzes a significant amount of health data, including blood tests, radiology scans, and lifestyle metrics, to provide individuals with a holistic view of their health. Key achievements include:

  • Product Development: Everlab's AI-powered platform supports the identification of potential health risks through advanced diagnostics, including whole-body MRI scans and comprehensive blood tests.
  • Service Excellence: The company provides a unique membership model that pairs health data with expert medical advice, ensuring customers can access tailored treatment plans efficiently.
  • Technological Innovation: By leveraging AI, Everlab has reduced the time needed for preventive health reviews and facilitated interoperability within existing health systems.
  • Market Expansion: With a vision for global health improvement, Everlab is expanding its operations beyond Australia, aiming to set a new standard for preventive care through advanced technology.

Current Operations and Market Position

Currently, Everlab is regarded as a leader in preventive health solutions, primarily due to its innovative use of AI and personalized health assessments. The company is expanding its operations across Australia and planning for international extension, focusing heavily on enhancing its clinic networks and digital infrastructure. Everlab maintains a competitive position by aligning its growth strategy with cutting-edge technology to meet the increasing demands for proactive healthcare management.

Conclusion

Everlab's significance in the health technology industry is marked by its innovative approach to preventive healthcare. By integrating AI and comprehensive health assessments, it supports a proactive stance on health management, offering personalized services designed to detect diseases early and optimize well-being. As it continues to grow and expand its reach, Everlab is well-positioned to influence the global health landscape, potentially setting a new benchmark for preventive healthcare standards.